Last reviewed · How we verify
Hemospray
At a glance
| Generic name | Hemospray |
|---|---|
| Also known as | Dust adsorption |
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- HemosprayTM for Gastrointestinal Bleeding From Cancer (NA)
- Efficacy of a Novel Hemostatic Powder in GI Bleeding
- Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions (NA)
- To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes (PHASE3)
- Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study (NA)
- Prognostic Factors in Malignant GI Bleeding Treated With Hemostatic Powder
- Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort
- Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |